Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall …

Oct 28, 2024 · Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Alnylam (ALNY), delve into some of its key metrics to gain a deeper insight into the company's …

CouponFollow Extension

$0.51
OFF

Seeking Clues To Alnylam (ALNY) Q3 Earnings? A Peek Into Wall …

3 weeks from now

Oct 28, 2024 · Analysts on Wall Street project that Alnylam Pharmaceuticals (ALNY) will announce quarterly loss of $0.51 per share in its forthcoming report, representing a decline of …

nasdaq.com

3%
OFF

Alnylam (ALNY) Reports Q3 Earnings: What Key Metrics Have To Say

3 weeks from now

Oct 31, 2024 · Alnylam Pharmaceuticals (ALNY) reported $500.92 million in revenue for the quarter ended September 2024, representing a year-over-year decline of 33.3%. EPS of …

yahoo.com

184%
OFF

Alnylam (ALNY) Q3 Earnings: Taking A Look At Key Metrics

3 weeks from now

Nov 2, 2023 · For the quarter ended September 2023, Alnylam Pharmaceuticals (ALNY) reported revenue of $750.53 million, up 184% over the same period last year. EPS came in at $1.15, …

nasdaq.com

184%
OFF

Alnylam (ALNY) Q3 Earnings: Taking A Look At Key Metrics Versus …

3 weeks from now

Nov 2, 2023 · For the quarter ended September 2023, Alnylam Pharmaceuticals (ALNY) reported revenue of $750.53 million, up 184% over the same period last year. EPS came in at $1.15, …

yahoo.com

$500.92
OFF

Alnylam (ALNY) Reports Q3 Earnings: What Key Metrics Have To Say

3 weeks from now

Oct 31, 2024 · Alnylam Pharmaceuticals (ALNY Quick Quote ALNY - Free Report) reported $500.92 million in revenue for the quarter ended September 2024, representing a year-over …

zacks.com

$1.15
OFF

Alnylam (ALNY) Swings To Earnings In Q3 On Collaboration Revenues

3 weeks from now

Nov 3, 2023 · Alnylam Pharmaceuticals, Inc. ALNY reported third-quarter 2023 earnings of $1.15 per share due to higher revenues from collaborators. The Zacks Consensus Estimate was …

nasdaq.com

3%
OFF

Alnylam (ALNY) Reports Q3 Earnings: What Key Metrics Have To Say

3 weeks from now

Oct 31, 2024 · Alnylam Pharmaceuticals (ALNY) reported $500.92 million in revenue for the quarter ended September 2024, representing a year-over-year decline of 33.3%. EPS of …

nasdaq.com

$111
OFF

Alnylam: Q3 Earnings Snapshot - Yahoo Finance

3 weeks from now

Oct 31, 2024 · CAMBRIDGE, Mass. AP) — Alnylam Pharmaceuticals Inc. ALNY) on Thursday reported a third-quarter loss of $111.6 million, after reporting a profit in the same period a year …

yahoo.com

2%
OFF

Alnylam's (ALNY) Q3 Earnings & Revenues Fall Shy Of Estimates

3 weeks from now

Oct 29, 2021 · Shares of Alnylam were down 15.2% on Thursday following the announcement of weaker-than-expected earnings results. The stock has rallied 24.8% so far this year against …

nasdaq.com

$0.71
OFF

Seeking Clues To Alnylam (ALNY) Q2 Earnings? A Peek Into Wall …

3 weeks from now

Jul 30, 2024 · Wall Street analysts forecast that Alnylam Pharmaceuticals (ALNY) will report quarterly loss of $0.71 per share in its upcoming release, pointing to a year-over-year increase …

nasdaq.com

FAQs about Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall … Coupon?

How did Alnylam Pharmaceuticals perform in the quarter ended September 2023?

For the quarter ended September 2023, Alnylam Pharmaceuticals (ALNY) reported revenue of $750.53 million, up 184% over the same period last year. EPS came in at $1.15, compared to -$3.32 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $406.14 million, representing a surprise of +84.80%. ...

How did Alnylam perform in the just reported quarter?

Here is how Alnylam performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Product revenues, net: $313.15 million compared to the $316.65 million average estimate based on 10 analysts. The reported number represents a change of +34.8% year over year. ...

What happened to Alnylam Pharmaceuticals?

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Alnylam Pharmaceuticals Inc. (ALNY) on Thursday reported a third-quarter loss of $111.6 million, after reporting a profit in the same period a year earlier. The Cambridge, Massachusetts-based company said it had a loss of 87 cents per share. ...

Did gurufocus detect a warning sign with Alnylam Pharmaceuticals Inc (ALNY)?

GuruFocus has detected 4 Warning Sign with ALNY. For the complete transcript of the earnings call, please refer to the full earnings call transcript. Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) achieved 34% year-over-year growth in global net product revenue, generating $420 million across its four marketed products. ...

Why did Alnylam Pharmaceuticals stop clinical development?

The company decided to stop clinical development of ALN-KHK, an investigational RNAi therapeutic targeting ketohexokinase for type 2 diabetes mellitus, to optimize resource allocation. Alnylam Pharmaceuticals Inc (ALNY) reports impressive 34% year-over-year revenue growth, advances in clinical programs, and strategic financial management. ...